GlassScriptPhysician profile
Adrienne Mucha
NPI 1407957913
$428.83
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $304 · 2022: $46.84 · 2023: $77.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $77.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $77.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $65.80 | 2021-2022 | |
| Cranial Technologies, INC | $48.13 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.66 | 2021 | |
| Pfizer INC. | $33.25 | 2021 | |
| Adlon Therapeutics L.P. | $28.54 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.50 | 2021 | |
| Alexion Pharmaceuticals, INC. | $21.76 | 2023 | Ultomiris |
| Genentech USA, INC. | $21.71 | 2021 | |
| Nevro Corp. | $20.27 | 2023 | Senza |
| Exact Sciences Corporation | $19.11 | 2023 | Cologuard Collection Kit |
| Neurelis, INC. | $16.53 | 2021 | |
| Lundbeck LLC | $16.47 | 2023 | Vyepti |
| Teva Pharmaceuticals USA, INC. | $15.77 | 2021 | |
| Philips North America LLC | $14.33 | 2022 | |
| Sobi, INC | $13.72 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $13.29 | 2021 | |
| Vistapharm, INC. | $12.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrienne Mucha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.